Design and synthesis of selective alpha1B adrenoceptor antagonists.

Bioorg Med Chem Lett

Pharmaceutical Research Laboratories, Toray Industries, Inc., 1111 Tebiro, Kamakura, Kanagawa 248-8555, Japan.

Published: August 2006

A series of novel indolylpiperidine derivatives were synthesized and assessed for their pharmacological profiles at alpha1 adrenoceptor subtypes by in vitro binding studies at rat alpha1A and alpha1B receptors. Compound 11 was a potent (Ki=0.63 nM) and selective (approximately 30-fold more selective for the alpha1B receptor than for the alpha1A receptor) alpha1B adrenoceptor antagonist.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.05.002DOI Listing

Publication Analysis

Top Keywords

selective alpha1b
8
alpha1b adrenoceptor
8
design synthesis
4
synthesis selective
4
alpha1b
4
adrenoceptor antagonists
4
antagonists series
4
series novel
4
novel indolylpiperidine
4
indolylpiperidine derivatives
4

Similar Publications

Enhanced vasoconstriction in sickle cell disease is dependent on ETA receptor activation.

Clin Sci (Lond)

December 2024

Section of Cardiorenal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, U.S.A.

Article Synopsis
  • * In research using mice, SCD was found to enhance vasoconstriction (narrowing of blood vessels) through the alpha-1 adrenergic receptor, particularly by increasing the expression of the alpha-1a receptor in the aortic tissue of SCD mice compared to controls.
  • * Treatment with ambrisentan, an ETA receptor blocker, improved blood vessel function in both mice and SCD patients, suggesting that targeting the ET-1 pathway could help improve vascular health in individuals with
View Article and Find Full Text PDF

Identification of Plasma Protein Biomarkers for Predicting Lung Cancer.

Anticancer Res

November 2024

Target Link Therapeutics Incorporation, Seoul, Republic of Korea;

Background/aim: Lung cancer remains a leading cause of cancer-related mortality worldwide, necessitating the development of effective early diagnostic strategies. Despite advancements in imaging and screening technologies, late-stage diagnoses remain common, limiting treatment options and reducing survival rates. Thus, there is a critical need for reliable, minimally invasive biomarkers to improve early detection and patient outcomes.

View Article and Find Full Text PDF

Stigmasterol is a sterol compound found in various traditional Chinese medicines; however, its effects on glioma remain unclear. The present study aimed to investigate the effects of stigmasterol on the biological behaviors of glioblastoma (GBM) cells and to explore the underlying mechanisms. experiments assessed its effects on GBM cell proliferation, apoptosis, cell cycle progression, invasion, migration and vasculogenic mimicry (VM).

View Article and Find Full Text PDF

The liver plays a major role in glucose and lipid homeostasis and acts as a key organ in the pathophysiology of metabolic diseases. Intriguingly, increased sympathetic nervous system (SNS) activity to the liver has been associated with the development and progression of type 2 diabetes and obesity. However, the precise mechanisms by which the SNS regulates hepatic metabolism remain to be defined.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how ganciclovir combined with recombinant human interferon affects the clinical outcomes and immune functions in children with infectious mononucleosis (IM).
  • It involved a retrospective analysis of 120 hospitalized children, divided into a control group receiving ganciclovir alone and a study group receiving ganciclovir with interferon.
  • Results showed that the study group experienced faster recovery of symptoms, lower inflammatory cytokine levels, and improved T-lymphocyte profiles, indicating a beneficial effect of the combined treatment without significant side effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!